These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8378872)

  • 41. Study of acute mountain sickness during "rapid ascent" trekking to extreme altitude.
    Mistry G; Chandrashekhar Y; Sen U; Anand IS
    J Assoc Physicians India; 1993 Aug; 41(8):500-2. PubMed ID: 8294352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Etiology, clinical aspects and therapy of altitude sickness].
    Berghold F; Schobersberger W
    Wien Med Wochenschr; 1994; 144(7):125-9. PubMed ID: 8073777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of high altitude illness.
    Zafren K
    Travel Med Infect Dis; 2014; 12(1):29-39. PubMed ID: 24393671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can migraine prophylaxis prevent acute mountain sickness at high altitude?
    Kim MW; Kim M
    Med Hypotheses; 2011 Nov; 77(5):818-23. PubMed ID: 21856088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m.
    Siebenmann C; Bloch KE; Lundby C; Nussbamer-Ochsner Y; Schoeb M; Maggiorini M
    High Alt Med Biol; 2011; 12(2):169-77. PubMed ID: 21718165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-altitude-related disorders--Part I: Pathophysiology, differential diagnosis, and treatment.
    Rodway GW; Hoffman LA; Sanders MH
    Heart Lung; 2003; 32(6):353-9. PubMed ID: 14652526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-dose theophylline reduces symptoms of acute mountain sickness.
    Küpper TE; Strohl KP; Hoefer M; Gieseler U; Netzer CM; Netzer NC
    J Travel Med; 2008; 15(5):307-14. PubMed ID: 19006503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m.
    Bloch KE; Turk AJ; Maggiorini M; Hess T; Merz T; Bosch MM; Barthelmes D; Hefti U; Pichler J; Senn O; Schoch OD
    High Alt Med Biol; 2009; 10(1):25-32. PubMed ID: 19326598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Incidence, prevention and therapy of acute mountain sickness].
    Oelz O
    Schweiz Med Wochenschr; 1982 Apr; 112(14):492-5. PubMed ID: 7079685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nifedipine for the treatment of high altitude pulmonary edema.
    Deshwal R; Iqbal M; Basnet S
    Wilderness Environ Med; 2012 Mar; 23(1):7-10. PubMed ID: 22441082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute mountain sickness in children at 4380 meters in the Himalayas.
    Pradhan S; Yadav S; Neupane P; Subedi P
    Wilderness Environ Med; 2009; 20(4):359-63. PubMed ID: 20030445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Travelling to high altitude areas--acute high altitude sickness].
    Rostrup M
    Tidsskr Nor Laegeforen; 2002 Jun; 122(17):1692-4. PubMed ID: 12555615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medical therapy of altitude illness.
    Hackett PH; Roach RC
    Ann Emerg Med; 1987 Sep; 16(9):980-6. PubMed ID: 3307558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are we doing our best to educate travelers about the risks of acute mountain sickness? An on-site prospective study in the Himalayas.
    Paz A; Steinfeld I; Potasman I
    J Travel Med; 2007; 14(3):168-72. PubMed ID: 17437472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial selectins in acute mountain sickness and high-altitude pulmonary edema.
    Grissom CK; Zimmerman GA; Whatley RE
    Chest; 1997 Dec; 112(6):1572-8. PubMed ID: 9404756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research advances in pathogenesis and prophylactic measures of acute high altitude illness.
    Li Y; Zhang Y; Zhang Y
    Respir Med; 2018 Dec; 145():145-152. PubMed ID: 30509704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema.
    Joyce KE; Lucas SJE; Imray CHE; Balanos GM; Wright AD
    Expert Opin Pharmacother; 2018 Dec; 19(17):1891-1902. PubMed ID: 30307756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbon monoxide exposure on Denali: comparing the 2004 and 2005 climbing seasons.
    Roscoe C; Baker E; Johnston E; Sandven T; Gustafson C; Arndt T; Dow J
    Wilderness Environ Med; 2008; 19(1):15-21. PubMed ID: 18333664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.